The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 1, 2008, Pages 59-65

  Minozzi, Massimo ^a   Gerli, S ^b   Di Renzo, G C ^b   Papaleo, E ^c   Ferrari, A ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Bacterial vaginosis; Clindamycin vaginal cream; PHMB; Vaginitis

Indexed keywords

CLINDAMYCIN; MONOGIN; POLY(HEXAMETHYLENEBIGUANIDE); UNCLASSIFIED DRUG;

ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SOLUTION; DRUG TOLERABILITY; FEMALE; FUNGAL GENITAL INFECTION; GYNECOLOGIC DISEASE; HUMAN; INCIDENCE; INFESTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREGNANCY DISORDER; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; URINARY TRACT INFECTION; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINAL PRURITUS; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ANTI-BACTERIAL AGENTS; BIGUANIDES; CLINDAMYCIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; PATIENT COMPLIANCE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINOSIS, BACTERIAL;

EID: 41149166710     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. SOBEL ID. Vaginitis. N Engl J Med 1997; 337: 1896-1903.
2. GUIDANCE FOR INDUSTRY: BACTERIAL VAGINOSIS-DEVELOPING ANTIMICROBIAL DRUGS FOR TREATMENT. Draft guidance. US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), July; 1998
3. 1998 GUIDELINES FOR TREATMENT OF SEXUALLY TRANSMITTED DISEASES. US Dept. of Health and Human Services, Centers for Disease Control and Prevention. Recommendations and Repons 1998; 47(RR-I); I-i 18.
4. PAAVONEN J, MANGIONI C, MARTIN MA, WAJSZCZUK CP. Vaginal clindamycin and oral metroniclazole for bacterial vaginosis; a randomized trial. Obstet Gynecol 2000; 96: 256-260.
5. FISCHBACH F PETERSEN EE, WEISSENBACBER ER, MARTIUS J, HOSMANN J, MAYER II. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993: 82: 405-410.
6. FERRIS DG, LITAKER MS, WOODWARD L, MATHIS D, HENDRICH J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995; 41: 443-449.
7. RICHTER A, ANTON SE, KOCH P, DENNETT SL. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307-2335.
8. WEINSTEIN L, HENZEL MR, TSINA IW. Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation. Clin Ther 1994; 16: 930-934.
9. AMSEL R, TOTTEN PA, SPIEGEL CA, CHEN KCS, ESCHENBACB D, HOLMES KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
10. NUGENT RP, KROHN MA, HIILIER SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
11. KOCH GG, CARR GJ, AMARA IA, STOKES ME, URYNIAK TJ. Categorical data analysis. In: Berry DA, Ed. Statistical methodology in She pharmaceutical sciences. New York: Marcel Dekker; 1989. pp 391-475.
12. GERLI S, ROSSETTI D, DI RENZO GC. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study. Eur Rev Med Pharmacol Sci 2003; 7: 127-130.